Following yet another failed clinical trial testing a novel drug designed to break up the aggregations of toxic proteins thought to be the cause of …
Storyboard
Solving the Alzheimer's mystery
For decades the leading hypothesis driving most Alzheimer’s research looked at finding ways to reduce the build-up of toxic amyloid proteins in the brain. But every drug designed to target these proteins has failed in clinical trials. Now a growing number of scientists are looking for new ways to treat this terrible disease.
Much research into Alzheimer's focuses on the buildup of brain plaques as a primary cause, but the case is far from closed, particularly in the eyes …
Scientists at the University of Cambridge have taken cutting-edge sensors used to measure temperature changes within cells to gain fascinating new …
A new article in the Journal of Alzheimer's Disease Reports has proposed a novel hypothesis for the cause of Alzheimer’s disease. The article argues …
Researchers in Australia have found evidence that bacteria that live in the nose can make their way into the brain through nasal cavity nerves, …
Researchers at Northwestern Medicine have uncovered a mechanism they say contributes to the age-related accumulation of iron in the brain, a process …
Building on a growing body of evidence linking viral infections with neurodegenerative disease, a new study published in Nature Communications has …
An impressive new study is presenting robust evidence showing the toxic proteins thought to be the cause of Alzheimer’s disease may be produced in …
A new study published in the journal Nature Communications is suggesting a novel causal link between neurodegenerative diseases such as Alzheimer’s …
One interesting area of Alzheimer's research focuses on the relationship between cholesterol in the brain and onset of the disease, with studies …
